CA Patent

CA3159208A1 — Beta-hydroxybutyrate salt granule and methods for producing the same

Assigned to Nanjing Nutrabuilding Bio Tech Co Ltd · Expires 2022-08-09 · 4y expired

What this patent protects

Among others, the present invention provides beta-hydroxybutyrate (BHB) salt granules, comprising BHB salts and fillers.The present invention also provides methods for producing BHB salt granules, wherein the BHB salt granules are prepared by granulation process.The production m…

USPTO Abstract

Among others, the present invention provides beta-hydroxybutyrate (BHB) salt granules, comprising BHB salts and fillers.The present invention also provides methods for producing BHB salt granules, wherein the BHB salt granules are prepared by granulation process.The production methods may include (a) wet granulation; (b) extrusion; (c) spheronization; and (d) drying.

Drugs covered by this patent

Patent Metadata

Patent number
CA3159208A1
Jurisdiction
CA
Classification
Expires
2022-08-09
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Nutrabuilding Bio Tech Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.